journal article·2019-12-04Open access

Intelligent polymeric micelles for multidrug co-delivery and cancer therapy

Guangping Yu, Qian Ning, Zhongcheng Mo, Shengsong Tang

Abstract

Polymeric micelles (PMs) play a vital role in multidrug co-delivery and cancer treatment. However, the development of intelligent PMs further allows PMs to accurately -target tumour, selectively release cargo multidrug and increase uptake. Therefore, targets, controlled release and uptake of intelligent PMs should be paid more attention to improvement synergistic therapeutic outcomes and minimize side effects. In this review, tumour targeting of co-delivery intelligent PMs and its intracellular trafficking mechanisms were overviewed. And this review provides a comprehensive summarization of several intelligent co-delivery PMs. Such a system could control the multidrug to be released simultaneously or sequentially by special properties of tumour microenvironment (TME) (including acidic PH, redox, overexpressed enzyme, excessive temperature) and external environment trigger. Additionally, limitations, clinical translation and future perspectives of intelligent co-delivery PMs were also being discussed in this article.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Learning Key Laboratory for Pharmacoproteomics of Hunan Province, Institute of Pharmacy and Pharmacology, University of South China

Hunan Province Key Laboratory for Antibody-based Drug and Intelligent Delivery System, Hunan University of Medicine

Clinical Anatomy and Reproductive Medicine Application Institute, Department of Histology and Embryology, Hengyang Medical school, University of South China

Funding

National Natural Science Foundation of China · Hunan Provincial Science and Technology Plan Key Projects of China · Science and Technology Plan Key Projects of Hunan Province · Hunan Provincial University Innovation Platform Open Fund Project · Hunan Provincial Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.1038/nrc359910.1038/nrc3599 ↗
3. 10.1016/j.biomaterials.2015.07.02710.1016/j.biomaterials.2015.07.027 ↗
4. 10.1016/j.semcancer.2018.08.00910.1016/j.semcancer.2018.08.009 ↗
5. 10.1016/j.cell.2012.06.01310.1016/j.cell.2012.06.013 ↗
6. 10.1021/acs.molpharmaceut.6b0117110.1021/acs.molpharmaceut.6b01171 ↗
7. 10.1016/j.jconrel.2015.07.01110.1016/j.jconrel.2015.07.011 ↗
8. 10.1021/acs.bioconjchem.7b0022210.1021/acs.bioconjchem.7b00222 ↗
9. 10.1038/nrd268310.1038/nrd2683 ↗
10. 10.1124/mi.7.4.810.1124/mi.7.4.8 ↗
11. 10.1021/acs.molpharmaceut.7b0035510.1021/acs.molpharmaceut.7b00355 ↗
12. 10.2147/IJN.S13093810.2147/IJN.S130938 ↗
13. 10.1016/j.jconrel.2016.04.03410.1016/j.jconrel.2016.04.034 ↗
14. 10.1021/acsami.7b0368210.1021/acsami.7b03682 ↗
15. 10.1016/j.nano.2017.12.01710.1016/j.nano.2017.12.017 ↗
16. 10.2147/IJN.S14445210.2147/IJN.S144452 ↗
17. 10.1016/j.biomaterials.2013.05.00810.1016/j.biomaterials.2013.05.008 ↗
18. 10.1039/C4SM00871E10.1039/C4SM00871E ↗
19. 10.1007/s11095-018-2477-310.1007/s11095-018-2477-3 ↗
20. 10.1186/s12951-017-0316-z10.1186/s12951-017-0316-z ↗
21. 10.1016/j.biomaterials.2007.02.01310.1016/j.biomaterials.2007.02.013 ↗
22. 10.1021/acsami.5b1178910.1021/acsami.5b11789 ↗
23. 10.1016/j.biomaterials.2017.01.00810.1016/j.biomaterials.2017.01.008 ↗
24. 10.1016/j.colsurfb.2019.02.04310.1016/j.colsurfb.2019.02.043 ↗
25. 10.1021/acsnano.8b0794810.1021/acsnano.8b07948 ↗
26. 10.1016/j.jconrel.2018.02.01410.1016/j.jconrel.2018.02.014 ↗
27. 10.1016/j.actbio.2018.08.03610.1016/j.actbio.2018.08.036 ↗
28. 10.1016/j.jconrel.2018.08.03410.1016/j.jconrel.2018.08.034 ↗
29. 10.1016/j.ijpharm.2013.06.01710.1016/j.ijpharm.2013.06.017 ↗
30. 10.1021/acs.analchem.7b0144510.1021/acs.analchem.7b01445 ↗
31. 10.1073/pnas.180168211510.1073/pnas.1801682115 ↗
32. 10.1016/j.actbio.2018.05.03110.1016/j.actbio.2018.05.031 ↗
33. 10.1016/j.foodchem.2018.04.04810.1016/j.foodchem.2018.04.048 ↗
34. 10.1021/acs.langmuir.8b0107410.1021/acs.langmuir.8b01074 ↗
35. Pandey B, Patil N, Bhosle GS, et al. Amphiphilic glycopolypeptide star copolymer-based crosslinked nanocarriers for targeted and dual stimuli-responsive drug delivery. Bioconjug Chem. 2018.
36. 10.1016/j.actbio.2016.12.00510.1016/j.actbio.2016.12.005 ↗
37. 10.1021/acsami.6b1433910.1021/acsami.6b14339 ↗
38. 10.1016/j.biomaterials.2018.07.00610.1016/j.biomaterials.2018.07.006 ↗
39. 10.1016/j.jconrel.2012.05.02010.1016/j.jconrel.2012.05.020 ↗
40. 10.2147/IJN.S13823510.2147/IJN.S138235 ↗
41. 10.1016/j.jconrel.2018.12.03110.1016/j.jconrel.2018.12.031 ↗
42. 10.1021/acs.biomac.6b0091610.1021/acs.biomac.6b00916 ↗
43. Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against [PMIDA27557520].pdf.
44. 10.1021/acs.biomac.7b0103710.1021/acs.biomac.7b01037 ↗
45. 10.1111/j.1399-3011.1979.tb01730.x10.1111/j.1399-3011.1979.tb01730.x ↗
46. 10.2147/IJN.S11388210.2147/IJN.S113882 ↗
47. 10.1021/acsnano.5b0132410.1021/acsnano.5b01324 ↗
48. 10.1016/j.jconrel.2014.12.01810.1016/j.jconrel.2014.12.018 ↗
49. 10.1016/j.ijpharm.2015.01.00910.1016/j.ijpharm.2015.01.009 ↗
50. 10.1021/acs.nanolett.7b0002110.1021/acs.nanolett.7b00021 ↗
51. 10.1016/j.jconrel.2017.05.01610.1016/j.jconrel.2017.05.016 ↗
52. 10.1080/17425247.2017.130733810.1080/17425247.2017.1307338 ↗
53. 10.1016/j.jconrel.2017.04.03310.1016/j.jconrel.2017.04.033 ↗
54. 10.2147/IJN.S15019610.2147/IJN.S150196 ↗
55. 10.1021/acsami.7b1223310.1021/acsami.7b12233 ↗
56. 10.1208/s12249-018-1070-810.1208/s12249-018-1070-8 ↗
57. 10.1016/j.jconrel.2018.08.03810.1016/j.jconrel.2018.08.038 ↗
58. 10.1021/acs.molpharmaceut.5b0022210.1021/acs.molpharmaceut.5b00222 ↗
59. 10.1016/j.nano.2017.12.01010.1016/j.nano.2017.12.010 ↗
60. 10.1002/jbm.b.3363610.1002/jbm.b.33636 ↗
61. 10.2967/jnumed.113.13307410.2967/jnumed.113.133074 ↗
62. 10.1039/C8NR04657C10.1039/C8NR04657C ↗
63. 10.18632/oncotarget.977110.18632/oncotarget.9771 ↗
64. 10.1007/s00204-014-1424-210.1007/s00204-014-1424-2 ↗
65. 10.1038/cdd.2014.15610.1038/cdd.2014.156 ↗
66. 10.1517/13543776.2014.91594210.1517/13543776.2014.915942 ↗
67. 10.1016/j.ejpb.2016.11.03310.1016/j.ejpb.2016.11.033 ↗
68. 10.1038/onc.2015.42510.1038/onc.2015.425 ↗
69. 10.1080/1061186X.2016.123611310.1080/1061186X.2016.1236113 ↗
70. 10.1039/C8NR05099F10.1039/C8NR05099F ↗
71. 10.1016/j.jconrel.2017.10.03610.1016/j.jconrel.2017.10.036 ↗
72. Ahangarzadeh S, Bandehpour M, Kazemi B. Selection of single-chain variable fragments specific for Mycobacterium tuberculosis ESAT-6 antigen using ribosome display. Iran J Basic Med Sci. 2017;20:327–333.
73. 10.1039/C6SC02403C10.1039/C6SC02403C ↗
74. 10.1016/j.ejpb.2016.08.01310.1016/j.ejpb.2016.08.013 ↗
75. 10.1016/j.actbio.2017.08.02710.1016/j.actbio.2017.08.027 ↗
76. 10.1021/acsami.7b1824510.1021/acsami.7b18245 ↗
77. 10.1016/j.msec.2017.04.13710.1016/j.msec.2017.04.137 ↗
78. 10.1080/09205063.2016.123688310.1080/09205063.2016.1236883 ↗
79. 10.1016/j.smim.2014.01.00810.1016/j.smim.2014.01.008 ↗
80. 10.1016/j.msec.2017.08.02610.1016/j.msec.2017.08.026 ↗
81. 10.1016/j.actbio.2017.07.01810.1016/j.actbio.2017.07.018 ↗
82. 10.1016/j.colsurfb.2015.12.02510.1016/j.colsurfb.2015.12.025 ↗
83. 10.1002/jbm.a.3543410.1002/jbm.a.35434 ↗
84. 10.1016/j.actbio.2017.01.03110.1016/j.actbio.2017.01.031 ↗
85. 10.1016/j.carbpol.2015.10.05010.1016/j.carbpol.2015.10.050 ↗
86. 10.1016/j.ijpharm.2016.04.06010.1016/j.ijpharm.2016.04.060 ↗
87. 10.1021/am503920m10.1021/am503920m ↗
88. 10.1016/j.colsurfb.2017.12.00810.1016/j.colsurfb.2017.12.008 ↗
89. 10.1016/j.biomaterials.2017.12.00610.1016/j.biomaterials.2017.12.006 ↗
90. 10.1021/acs.langmuir.7b0371510.1021/acs.langmuir.7b03715 ↗
91. 10.7150/thno.1351510.7150/thno.13515 ↗
92. 10.1080/1061186X.2016.120764910.1080/1061186X.2016.1207649 ↗
93. 10.1021/acsami.6b0424710.1021/acsami.6b04247 ↗
94. 10.1021/la303449d10.1021/la303449d ↗
95. 10.1016/j.jconrel.2004.11.00610.1016/j.jconrel.2004.11.006 ↗
96. 10.1021/acs.molpharmaceut.8b0084210.1021/acs.molpharmaceut.8b00842 ↗
97. 10.1016/j.colsurfb.2018.05.02510.1016/j.colsurfb.2018.05.025 ↗
98. 10.1016/j.colsurfb.2015.01.03910.1016/j.colsurfb.2015.01.039 ↗
99. 10.1021/bm500850810.1021/bm5008508 ↗
100. 10.2147/IJN.S14827310.2147/IJN.S148273 ↗